ASH 2016 MPN News: Reviving the Role of Interferon Treatment

Description: As part of our ASH 2016 coverage, Dr. John Mascarenhas, from Mount Sinai School of Medicine, joined Patient Power to discuss the research taking place with interferon as a treatment for myeloproliferative neoplasms (MPNs). While interferon has been around for some time, there’s a recent re-emergence of research in the field. Dr. Mascarenhas addresses the interim results of current studies and the new clinical trials set to begin in 2017. Learn more about interferon and why this may be a viable option for some patients with MPNs.

Get email alerts | http://www.patientpower.inf...

Subscribe on YouTube |
Like on Facebook |
Follow on Twitter |
Follow on Google+ |
Shared By : P2Professional
Posted on : 01/24/17
Added : 2 years ago